166 related articles for article (PubMed ID: 3966729)
41. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
42. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Waldhäusl W
Horm Metab Res; 1996 Sep; 28(9):517-21. PubMed ID: 8911990
[No Abstract] [Full Text] [Related]
43. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.
Leonard CE; Hennessy S; Han X; Siscovick DS; Flory JH; Deo R
Trends Endocrinol Metab; 2017 Aug; 28(8):561-586. PubMed ID: 28545784
[TBL] [Abstract][Full Text] [Related]
44. Insulin responses to sulfonylureas.
Cerasi E
Diabetes Res Clin Pract; 2002 Apr; 56(1):69-70; author reply 71. PubMed ID: 11879723
[No Abstract] [Full Text] [Related]
45. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
46. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
Al-Ozairi E; Sibal L; Home P
Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288
[No Abstract] [Full Text] [Related]
47. Beyond sulfonylureas: new oral medications in the treatment of NIDDM (type II DM).
Capriotti T
Medsurg Nurs; 1997 Jun; 6(3):166-9. PubMed ID: 9238992
[No Abstract] [Full Text] [Related]
48. Oral sulfonylureas and CV mortality.
Aronow WS
Geriatrics; 2004 Sep; 59(9):45-6, 49. PubMed ID: 15461238
[No Abstract] [Full Text] [Related]
49. Sulphonylureas, magnesium and cardiac K+ ATP channels.
Matz R
Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
[No Abstract] [Full Text] [Related]
50. Do sulfonylureas influence hepatic insulin clearance?
Groop LC; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
Diabetes Care; 1988 Sep; 11(8):689-90. PubMed ID: 3065007
[No Abstract] [Full Text] [Related]
51. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
Scheen AJ
Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
[TBL] [Abstract][Full Text] [Related]
52. Actual problems of the hypoglycaemic sulfonylureas.
Káldor A
Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
[No Abstract] [Full Text] [Related]
53. [Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
Iori I; Bosi E; Manicardi E; Del Din G; Dini FL; Portioli I
Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):277-83. PubMed ID: 2640049
[TBL] [Abstract][Full Text] [Related]
54. The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
Tuccori M; Wu JW; Yin H; Majdan A; Azoulay L
Diabetes Care; 2015 Nov; 38(11):2083-9. PubMed ID: 26341130
[TBL] [Abstract][Full Text] [Related]
55. Does mortality risk vary among sulfonylureas?
Pantalone KM
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):6-7. PubMed ID: 25466240
[No Abstract] [Full Text] [Related]
56. Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?
Riddle MC
J Clin Endocrinol Metab; 2003 Feb; 88(2):528-30. PubMed ID: 12574174
[No Abstract] [Full Text] [Related]
57. [Sulfonylureas and glinides].
Hirose T
Nihon Rinsho; 2006 Dec; 64 Suppl 9():646-53. PubMed ID: 17458297
[No Abstract] [Full Text] [Related]
58. Sulfonylureas: do we need to introspect safety again?
Sehra D; Sehra S; Sehra ST
Expert Opin Drug Saf; 2011 Nov; 10(6):851-61. PubMed ID: 21605015
[TBL] [Abstract][Full Text] [Related]
59. Comment on Genuth. Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it's time to move on! Diabetes Care 2015;38:170-175.
Schrijnders D; Houweling ST; Landman GW
Diabetes Care; 2015 Jun; 38(6):e94. PubMed ID: 25998308
[No Abstract] [Full Text] [Related]
60. Improving management of type 2 diabetes mellitus: 3. Sulfonylureas.
Samraj GP; Quillen DM; Kuritzky L
Hosp Pract (1995); 1999 Nov; 34(12):129-34, 137, 140. PubMed ID: 10616550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
